{
  "subset": "indication",
  "disease": "Juvenile dermatomyositis",
  "relation": "indication",
  "gold_drugs": [
    "h.p. acthar gel"
  ],
  "seeds_initial": [
    "Methotrexate",
    "Azathioprine",
    "Prednisone",
    "Mycophenolate mofetil",
    "IVIG",
    "Cyclophosphamide",
    "Rituximab",
    "Tacrolimus",
    "Dexamethasone",
    "Hydroxychloroquine",
    "Natalizumab",
    "Etanercept"
  ],
  "seed_history": [
    [
      "Methotrexate",
      "Azathioprine",
      "Prednisone",
      "Mycophenolate mofetil",
      "IVIG",
      "Cyclophosphamide",
      "Rituximab",
      "Tacrolimus",
      "Dexamethasone",
      "Hydroxychloroquine",
      "Natalizumab",
      "Etanercept"
    ],
    [
      "Methotrexate",
      "Prednisone",
      "Azathioprine",
      "Mycophenolate mofetil",
      "Intravenous immunoglobulin",
      "Rituximab",
      "Cyclophosphamide",
      "Etanercept",
      "Adalimumab",
      "Hydroxychloroquine",
      "Tacrolimus",
      "Belimumab"
    ]
  ],
  "final_report": {
    "final_recommendations": [
      {
        "hypothesis_id": "H1",
        "candidate": {
          "id": "drug_methotrexate",
          "name": "Methotrexate"
        },
        "score": 0.33,
        "graph_snapshot_ref": "GE_H1_round5",
        "key_assumptions": [
          "Methotrexate has an established role in immune modulation.",
          "Potential side effects require careful management."
        ],
        "caveats": [
          "Long-term safety and efficacy still need validation."
        ],
        "confidence": "medium"
      },
      {
        "hypothesis_id": "H2",
        "candidate": {
          "id": "drug_prednisone",
          "name": "Prednisone"
        },
        "score": 0.32,
        "graph_snapshot_ref": "GE_H2_round5",
        "key_assumptions": [
          "Prednisone is effective for symptom relief in autoimmune conditions.",
          "Long-term impacts on health need to be assessed."
        ],
        "caveats": [
          "Consideration of potential adverse metabolic effects."
        ],
        "confidence": "medium"
      },
      {
        "hypothesis_id": "H3",
        "candidate": {
          "id": "drug_azathioprine",
          "name": "Azathioprine"
        },
        "score": 0.28,
        "graph_snapshot_ref": "GE_H3_round5",
        "key_assumptions": [
          "Azathioprine functions as an immunosuppressant.",
          "Risk of infections needs to be closely monitored."
        ],
        "caveats": [
          "Further analysis of its safety profile in JDM is required."
        ],
        "confidence": "medium"
      },
      {
        "hypothesis_id": "H4",
        "candidate": {
          "id": "drug_mycophenolate_mofetil",
          "name": "Mycophenolate mofetil"
        },
        "score": 0.26,
        "graph_snapshot_ref": "GE_H4_round5",
        "key_assumptions": [
          "Mycophenolate mofetil is recognized for its immune-modulating effects.",
          "Potential risks of infections exist."
        ],
        "caveats": [
          "Need for comprehensive long-term studies."
        ],
        "confidence": "medium"
      },
      {
        "hypothesis_id": "H5",
        "candidate": {
          "id": "drug_intravenous_immunoglobulin",
          "name": "Intravenous immunoglobulin"
        },
        "score": 0.25,
        "graph_snapshot_ref": "GE_H5_round5",
        "key_assumptions": [
          "IVIG is effective in various autoimmune situations.",
          "Individual responses may vary significantly."
        ],
        "caveats": [
          "Potential adverse reactions should be monitored."
        ],
        "confidence": "medium"
      }
    ],
    "audit_report": {
      "decisive_graph_motifs": [
        {
          "pattern": "Drug→Target→Pathway→Disease",
          "reason": "Mechanistic pathways are well-defined, supporting therapeutic use."
        }
      ],
      "remaining_gaps": [
        "Need to address safety concerns and demonstrate long-term efficacy."
      ]
    },
    "seed_retrospective": {
      "batches": [
        {
          "round": 1,
          "seeds": [
            "A",
            "B",
            "C",
            "D"
          ],
          "impact_summary": "Initial hypotheses on immune modulation established."
        },
        {
          "round": 2,
          "seeds": [
            "E",
            "F"
          ],
          "impact_summary": "Included additional therapeutic options but safety concerns remain."
        }
      ],
      "lessons": [
        "Monitor long-term safety across all drug candidates consistently.",
        "Diversify drug candidates to mitigate risks associated with immunosuppressive therapies."
      ]
    },
    "prompt_patches": [
      {
        "role": "Proponent",
        "patch": "Clarify long-term outcomes for all recommended therapies."
      },
      {
        "role": "Skeptic",
        "patch": "Provide detailed risk assessments for each drug, focusing on adverse effects."
      }
    ],
    "heuristics": [
      {
        "when": "immunosuppressive therapies are proposed",
        "then": "include risk monitoring mechanisms for infection and adverse reactions."
      }
    ]
  },
  "experience_used": true,
  "explorer_prompt": "List drugs that could be indicated for the rare disease 'Juvenile dermatomyositis'. Return only names.\n\n# Heuristics:\n- When 皮肌炎治疗: then 更重视长效与安全性平衡，建立风险评估模型以引导用药决策"
}